ES71
TEAS SECTION 71 RECEIVED
06/29/2026
Back to search
Official data from USPTO
ALK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
69
Latest update
06/29/2026
Trademark type
Combined
Nice classes
1, 5, 44
Filing date
11/20/2013
Registration date
06/28/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/15/2022
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Hørsholm, DK
Examiner
STRUCK, ROBERT J
Law office
L90
Mark description
The mark consists of the stylized wording "ALK" with a design of dots forming part of the "A".
Holders and representatives
Holders
ALK-Abelló A/S
Representatives
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Technical classification
Nice Classes
Class 1Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in research and science; diagnostic preparations for scientific or research purposesdiagnostic preparations for the treatmentmonitoring and diagnosing of diseases such as allergiesasthmarhinitis and respiratory diseases
Class 5
Pharmaceutical and veterinary preparationspharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosisprevention and treatment of allergyasthmaallergic rhinitisallergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposesdiagnostic reagents for medical use; diagnostic testing kits comprised of diagnostic assaysspecimen holdersdiagnostic preparation agents and specimen preparation agents for medical use ; pharmaceutical preparations in the form of injectable pharmaceuticalsparticularly adrenalinefor treatment of anaphylactic reactions
Class 44
Medical services and medical healthcare services; medical consulting servicescounselling and information regarding immunotherapyallergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy as well as to diagnosingprevention and treatment of allergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactionsmedical consultations; providing medical information to medical professionals relating to immunotherapy as well as to diagnosingprevention and treatment of allergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactions; providing a website featuring medical information to medical professionals relating to immunotherapy as well as to diagnosingprevention and treatment of allergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactions; medical testing for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
69 publications found
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/28/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/25/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/23/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/08/2023
INPC
INVALIDATION PROCESSED
09/07/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/15/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/15/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/15/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/15/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/15/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
06/28/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/28/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/23/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/20/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/20/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
10/20/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/28/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/15/2016
IROP
IRREGULARITY ON NOTICE OF POSSIBLE OPPOSITION RECEIVED FROM IB
07/25/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2016
PUBO
PUBLISHED FOR OPPOSITION
04/12/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/23/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2015
GNRT
NON-FINAL ACTION E-MAILED
10/01/2015
CNRT
NON-FINAL ACTION WRITTEN
10/01/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/09/2015
ALIE
ASSIGNED TO LIE
09/03/2015
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/05/2015
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/05/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/30/2015
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/30/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/27/2015
GNSL
LETTER OF SUSPENSION E-MAILED
01/27/2015
CNSL
SUSPENSION LETTER WRITTEN
01/27/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2015
ALIE
ASSIGNED TO LIE
01/05/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/19/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/04/2014
GNFR
FINAL REFUSAL E-MAILED
12/04/2014
CNFR
FINAL REFUSAL WRITTEN
12/04/2014
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
11/26/2014
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
11/18/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2014
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/14/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/14/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2014
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
11/04/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/23/2014
RFNT
REFUSAL PROCESSED BY IB
05/30/2014
MAFR
APPLICATION FILING RECEIPT MAILED
05/16/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/14/2014
RFRR
REFUSAL PROCESSED BY MPU
05/14/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/14/2014
CNRT
NON-FINAL ACTION WRITTEN
05/13/2014
DOCK
ASSIGNED TO EXAMINER
05/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2014
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/08/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/08/2014
Continuous trademark protection
Get notified about every new filing that threatens ALK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.